Another Buying Opportunity in BSX (John Mugarian's Dynamic Growth)

Another Buying Opportunity in BSX

Shares of Boston Scientific (BSX- $21.89) are selling off in sympathy with St. Jude Medical (STJ-$36.15 down -$5.15) after the company cut its sales and earnings outlook.

An analyst at Stanford Financial Group, said "St. Jude was too optimistic about gaining market share from rival Guidant after the company's string of product recalls and warnings." In the days ahead, Guidant will become part of BSX.

INSIDERS BUYING

Insider buying has been very active at BSX. This sounds like a buying opportunity to me.

Posted by John Mugarian on April 5, 2006 11:48 AM | Permalink

Disclaimer—This is for informational purposes only and is in no way a solicitation or an offer to sell securities. I am a registered investment advisor, but only provide solicited advice to clients of our firm in states where we are registered or where an exemption or exclusion from such registration exists. nothing on this website should be interpreted to state or imply that past results are any indication of future performance. carefully assess your own risk tolerance and goals before investing.